{"schema_version":"1","generated_at":"2026-11-08T14:49:30.314Z","data_as_of":"2026-11-08","url":"https://www.findmykol.com/kol/elisa-agostinetto","json_url":"https://www.findmykol.com/kol/elisa-agostinetto/profile.json","record_kind":"full","profile_kind":"research","person":{"slug":"elisa-agostinetto","name":"Elisa Agostinetto","title":"Medical oncologist and breast cancer researcher","specialty":"Medicine","therapeutic_area":"Breast","therapeutic_areas":["Breast"],"institution":"Université Libre de Bruxelles","institution_url":"https://www.findmykol.com/institution/universit-libre-de-bruxelles","register":{"country":"BE"}},"identifiers":{"orcid":"0000-0003-0295-7511","openalex":"A5082230442"},"summary":"Elisa Agostinetto is Medical oncologist and breast cancer researcher at Université Libre de Bruxelles. OpenAlex indexes 194 publications with 2,992 citations (h-index 28).","overview":{"text":"Elisa Agostinetto is Medical oncologist and breast cancer researcher at Université Libre de Bruxelles (Faculté de Médecine). The public record shows 194 publications with 2,992 citations (h-index 28), centered on Breast Cancer Treatment Studies, Advanced Breast Cancer Therapies, BRCA gene mutations in cancer.","bullets":["Most recent indexed publication: 2026 · Journal of the National Cancer Institute","Top research focus: Breast Cancer Treatment Studies"],"generated_at":"2026-11-08"},"focus":{"indications":[{"label":"Lung Cancer (NSCLC/SCLC)","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Breast Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Gastroesophageal Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"COVID-19","therapeutic_area":"Infectious Disease","trials":0,"topics":0,"strength":1},{"label":"Ovarian / Gynecologic Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Sarcoma","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Neuro-Oncology / Glioma","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Obesity","therapeutic_area":"Endocrinology/Metabolic","trials":0,"topics":0,"strength":1}],"research_topics":["Breast Cancer Treatment Studies","Advanced Breast Cancer Therapies","BRCA gene mutations in cancer","HER2/EGFR in Cancer Research","Breast Lesions and Carcinomas"]},"scholarship":{"works_count":194,"cited_by_count":2992,"h_index":28,"i10_index":59,"pubmed_count":28,"latest_activity_year":2026,"source":"works"},"trials":{"shown":0,"withheld":0,"rows":[],"source":"trials"},"payments":{"note":"Not attributed. This person has no U.S. clinical registration (NPI) on file, so industry payments cannot be reliably tied to them."},"funding":{"award_count":0,"rows_total":0,"shown":0,"withheld":0,"rows":[],"source":"grants"},"congress":{"count":43,"years":{"first":2017,"last":2026},"societies":["AACR","ASCO","ESHRE Annual Meeting","ESMO"],"shown":3,"withheld":40,"rows":[{"title":"Impact of germline BRCA pathogenic or likely pathogenic variants on fertility potential and reproductive outcomes in young women with breast cancer: A systematic review and meta-analysis.","society":"ASCO","meeting":"ASCO Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco.2026.44.16_suppl.10606","source_url":"https://doi.org/10.1200/jco.2026.44.16_suppl.10606","status":"verified"},{"title":"Multi-omics analysis from the IMMUcan consortium to identify predictors of chemo-immunotherapy response in early-stage triple-negative breast cancer.","society":"ASCO","meeting":"ASCO Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco.2026.44.16_suppl.2588","source_url":"https://doi.org/10.1200/jco.2026.44.16_suppl.2588","status":"verified"},{"title":"Association between chemotherapy use and clinical outcomes in young BRCA carriers with T1N0 breast cancer: Results from an international cohort study.","society":"ASCO","meeting":"ASCO Annual Meeting","year":2025,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco.2025.43.16_suppl.541","source_url":"https://doi.org/10.1200/jco.2025.43.16_suppl.541","status":"verified"}],"source":"congress"},"publications":{"total":28,"shown":5,"withheld":23,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"The benefit of adjuvant pertuzumab and trastuzumab according to estrogen receptor and HER2 expression: a subanalysis of the APHINITY trial.","year":2026,"journal":"Journal of the National Cancer Institute","types":["Journal Article","Randomized Controlled Trial","Clinical Trial, Phase III","Multicenter Study"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/41934626/","status":"verified"},{"title":"Neoadjuvant stereotactic body radiation therapy with durvalumab and oleclumab in ER(+)HER2(-) breast cancer: a randomized phase 2 trial.","year":2026,"journal":"Nature medicine","types":["Journal Article","Clinical Trial, Phase II","Randomized Controlled Trial","Multicenter Study"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42350643/","status":"verified"},{"title":"Molecular and Clinical Analyses of Gene Fusions Identify Therapeutic Targets in Paired Primary and Metastatic Breast Cancer from the AURORA Program (BIG 14-01).","year":2026,"journal":"Clinical cancer research : an official journal of the American Association for Cancer Research","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/41427961/","status":"verified"},{"title":"Palbociclib and endocrine therapy diminish adaptive anti-tumor immunity in early breast cancer: The NeoRHEA phase 2 study.","year":2025,"journal":"Nature communications","types":["Journal Article","Clinical Trial, Phase II","Research Support, Non-U.S. Gov't"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/41298425/","status":"verified"},{"title":"Breastfeeding after breast cancer in young BRCA carriers.","year":2025,"journal":"Journal of the National Cancer Institute","types":["Journal Article","Multicenter Study","Observational Study"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/40623009/","status":"verified"}],"source":"publications"},"presence":{"owned_accounts":{"total":1,"shown":1,"rows":[{"platform":"x","url":"https://x.com/ElisaAgostinett","status":"verified"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"social_posts":{"stored_total":18,"shown":3,"withheld":15,"rows":[{"platform":"x","post_id":"2114660063910486083","url":"https://x.com/elisaagostinett/status/2114660063910486083","handle":"elisaagostinett","posted_at_from_id":"2026-10-26T10:07:02.377Z","collected_at":"2026-11-05T21:43:34.520Z","sources":[{"hub":"esmo26","society_slug":"esmo","meeting_year":2026,"relevance":"explicit_hashtag","source_urls":["https://kolpulse.com/kol-pulse-trial-profile-destinybreast09"]}]},{"platform":"x","post_id":"2114657049116385629","url":"https://x.com/elisaagostinett/status/2114657049116385629","handle":"elisaagostinett","posted_at_from_id":"2026-10-26T09:55:03.594Z","collected_at":"2026-11-05T21:43:34.520Z","sources":[{"hub":"esmo26","society_slug":"esmo","meeting_year":2026,"relevance":"explicit_hashtag","source_urls":["https://kolpulse.com/kol-pulse-trial-profile-bridget"]}]},{"platform":"x","post_id":"2114655353925234705","url":"https://x.com/elisaagostinett/status/2114655353925234705","handle":"elisaagostinett","posted_at_from_id":"2026-10-26T09:48:19.429Z","collected_at":"2026-11-05T21:43:34.520Z","sources":[{"hub":"esmo26","society_slug":"esmo","meeting_year":2026,"relevance":"explicit_hashtag","source_urls":["https://kolpulse.com/kol-pulse-trial-profile-switch"]}]}],"coverage":"Saved references from selected congress pages, joined through reviewed account identifiers. Not a complete X history or evidence of attendance. Post availability may change."},"recognition":{"education":{"total":2,"shown":2,"rows":[{"value":"Doctorat en sciences médicales (doctorate in medical sciences), ULB, thesis \"Immunotherapy in Breast Cancer\", public defence 22 April 2026","source_url":"https://www.ulb.be/fr/agenda-soutenances-de-theses/agostinetto-elisa-faculte-de-medecine","status":"verified","collected_at":"2026-11-08"},{"value":"Medical degree, University of Udine (Italy), per third-party profile","source_url":"https://www.vjoncology.com/speaker/elisa-agostinetto/","status":"provisional","collected_at":"2026-11-08"}]},"roles":{"total":4,"shown":3,"rows":[{"value":"Member, European Society for Medical Oncology (ESMO)","source_url":"https://oncodaily.com/societies/elisa-agostinetto-66898","status":"provisional","collected_at":"2026-11-08"},{"value":"Member, American Society of Clinical Oncology (ASCO)","source_url":"https://oncodaily.com/societies/elisa-agostinetto-66898","status":"provisional","collected_at":"2026-11-08"},{"value":"Member, Belgian Society of Medical Oncology (BSMO)","source_url":"https://oncodaily.com/societies/elisa-agostinetto-66898","status":"provisional","collected_at":"2026-11-08"}]},"awards":{"total":2,"shown":2,"rows":[{"value":"touchONCOLOGY Future Leader 2026","source_url":"https://touchoncology.com/insight/fl-elisa-agostinetto-touchoncology-2026/","status":"provisional","collected_at":"2026-11-08"},{"value":"Early Investigator Award, San Antonio Breast Cancer Symposium","source_url":"https://new.oncodaily.com/insight/205147","status":"provisional","collected_at":"2026-11-08"}]},"secondary_affiliations":{"total":2,"shown":2,"rows":[{"value":"Medical Research Fellow, University Hospital of Brussels (HUB), since November 2021","source_url":"https://inventaire.ulb.be/Site/unite/COM290UK.php","status":"provisional","collected_at":"2026-11-08"},{"value":"Institut Jules Bordet (Brussels), breast cancer researcher and medical oncologist","source_url":"https://touchoncology.com/insight/fl-elisa-agostinetto-touchoncology-2026/","status":"provisional","collected_at":"2026-11-08"}]},"media":{"total":2,"shown":2,"rows":[{"value":"Audio Journal of Oncology episode: EBCC 2026, circulating tumor DNA after neoadjuvant therapy in early breast cancer","source_url":"https://next.audiomedica.com/episode/elisa-agostinetto-md-2026-ebcc-circulating-tumor-dna-trumps-clinical-prognostic-markers-after-neoadjuvant-therapy-for-patients-with-early-breast-cancer","status":"provisional","collected_at":"2026-11-08"},{"value":"OncoDaily interview: \"San Antonio Breast Cancer Symposium is my favourite congress of the year\"","source_url":"https://new.oncodaily.com/insight/205147","status":"provisional","collected_at":"2026-11-08"}]}},"similar":[{"name":"Antoine Bondue","slug":"antoine-bondue","institution":"Université Libre de Bruxelles","url":"https://www.findmykol.com/kol/antoine-bondue","json_url":"https://www.findmykol.com/kol/antoine-bondue/profile.json"},{"name":"Jean‐Louis Vincent","slug":"jeanlouis-vincent","institution":"Université Libre de Bruxelles","url":"https://www.findmykol.com/kol/jeanlouis-vincent","json_url":"https://www.findmykol.com/kol/jeanlouis-vincent/profile.json"},{"name":"Martine J Piccart","slug":"martine-piccart","institution":"Université Libre de Bruxelles","url":"https://www.findmykol.com/kol/martine-piccart","json_url":"https://www.findmykol.com/kol/martine-piccart/profile.json"},{"name":"Christos P. Sotiriou","slug":"christos-sotiriou","institution":"Université Libre de Bruxelles","url":"https://www.findmykol.com/kol/christos-sotiriou","json_url":"https://www.findmykol.com/kol/christos-sotiriou/profile.json"},{"name":"Gabriel Hortobagyi","slug":"gabriel-hortobagyi","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/gabriel-hortobagyi","json_url":"https://www.findmykol.com/kol/gabriel-hortobagyi/profile.json"},{"name":"Eric Winer","slug":"eric-winer","institution":"Yale School of Medicine","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/eric-winer","json_url":"https://www.findmykol.com/kol/eric-winer/profile.json"},{"name":"Norman Wolmark","slug":"norman-wolmark","institution":"University of Pittsburgh","specialty":"Surgical Oncology","url":"https://www.findmykol.com/kol/norman-wolmark","json_url":"https://www.findmykol.com/kol/norman-wolmark/profile.json"},{"name":"Hope Rugo","slug":"hope-rugo","institution":"City of Hope","specialty":"Hematology","url":"https://www.findmykol.com/kol/hope-rugo","json_url":"https://www.findmykol.com/kol/hope-rugo/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"congress":40,"publications":23,"social_posts":15}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-11-08"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"},"congress":{"name":"OpenAlex","url":"https://openalex.org","provides":"DOI-verified congress abstracts across AACR, ASCO, ASH, ASTRO, ESMO","disclaimer":"Congress abstracts are published as DOI-bearing journal supplements and attributed via the same ORCID-disambiguated authorship as publications.","collected_at":"2026-11-08"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-11-08"}},"methodology_url":"https://www.findmykol.com/about#methodology"}